You just read:

Akcea Therapeutics Receives Orphan Designation in Europe for Volanesorsen for the Treatment of Familial Partial Lipodystrophy (FPL)

News provided by

Ionis Pharmaceuticals, Inc.

28 Jul, 2016, 16:00 ET